Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Pak Med Assoc ; 74(5): 987-989, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38783453

RESUMO

Thyroid hemiagenesis is defined as a failure of one thyroid lobe development. This condition predominantly manifests as an incidental finding during radiological investigation. This paper repor ts the case o f a 53-year-ol d female, a known case of hypertension, who visited the ENT clinic at AKU, a ter tiary ca re centre in Karachi, Pak istan and was hospi talized from 12 th to 1 5th Septembe r 202 1. The patient presented with hemiagenesis of the right thyroid lobe with enlargement of the contralateral lobe resulting in airway compression. She was subjected to excision of the thyroid gland without any intra-operative or postoperative com plicati ons. There were n o complaints o f dyspnoea, stridor or hoarseness during the hospital stay. The patient was discharged and was found to be well on subsequent follow-ups.


Assuntos
Hipertrofia , Glândula Tireoide , Humanos , Feminino , Pessoa de Meia-Idade , Glândula Tireoide/anormalidades , Glândula Tireoide/diagnóstico por imagem , Tireoidectomia/métodos , Disgenesia da Tireoide/complicações , Disgenesia da Tireoide/cirurgia , Disgenesia da Tireoide/diagnóstico por imagem , Disgenesia da Tireoide/diagnóstico
2.
J Pak Med Assoc ; 74(4 (Supple-4)): S109-S116, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38712418

RESUMO

Breast Cancer (BC) has evolved from traditional morphological analysis to molecular profiling, identifying new subtypes. Ki-67, a prognostic biomarker, helps classify subtypes and guide chemotherapy decisions. This review explores how artificial intelligence (AI) can optimize Ki-67 assessment, improving precision and workflow efficiency in BC management. The study presents a critical analysis of the current state of AI-powered Ki-67 assessment. Results demonstrate high agreement between AI and standard Ki-67 assessment methods highlighting AI's potential as an auxiliary tool for pathologists. Despite these advancements, the review acknowledges limitations such as the restricted timeframe and diverse study designs, emphasizing the need for further research to address these concerns. In conclusion, AI holds promise in enhancing Ki-67 assessment's precision and workflow efficiency in BC diagnosis. While challenges persist, the integration of AI can revolutionize BC care, making it more accessible and precise, even in resource-limited settings.


Assuntos
Inteligência Artificial , Neoplasias da Mama , Antígeno Ki-67 , Fluxo de Trabalho , Humanos , Neoplasias da Mama/metabolismo , Neoplasias da Mama/patologia , Neoplasias da Mama/diagnóstico , Antígeno Ki-67/metabolismo , Feminino , Biomarcadores Tumorais/metabolismo
3.
Int J Surg Case Rep ; 107: 108333, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-37216733

RESUMO

INTRODUCTION: Adenoid cystic carcinoma is a neoplasm that is commonly of salivary gland origin. It could infrequently arise from other tissues such as breast in which case it behaves favorably despite belonging to triple-negative breast cancer subgroup. CASE PRESENTATION: We report a case of a 49-year-old female patient, who presented with right breast pain and upon work-up, was diagnosed with early-stage adenoid cystic carcinoma of the breast. She underwent breast conservation successfully and was advised to get evaluated for adjuvant radiotherapy. The work has been reported in line with the SCARE criteria (Agha et al., 2020). CLINICAL DISCUSSION: Breast adenoid cystic carcinoma (BACC) is a rare distinct salivary gland-like carcinoma of the breast with similar morphological features to those seen in salivary gland adenoid cystic carcinoma. Surgical resection is the standard mode of treatment in BACC. The role of adjuvant chemotherapy has not proven beneficial in the management of BACC, owing to the similar survival rates seen in patients with and without chemotherapy. CONCLUSION: Localized breast adenoid cystic carcinoma (BACC) is an indolent disease having optimal response to surgical resection alone and thus can omit adjuvant radiotherapy and chemotherapy when completely excised. Our case is unique as BACC is a rare clinical variant of breast cancer with a very low incidence rate.

4.
J Coll Physicians Surg Pak ; 28(9): 677-680, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30158032

RESUMO

OBJECTIVE: To determine maternal and neonatal outcome in planned induction of labor versus expectant management in mild pre-eclampsia at term. STUDY DESIGN: Quasi-experimental study. PLACE AND DURATION OF STUDY: Department of Gynecology and Obstetrics, Sir Ganga Ram Hospital, Lahore, from July to December 2016. METHODOLOGY: After taking informed consent, 200 females fulfilling the inclusion criteria were included in the study. Sample was equally divided into two groups. In Group A (induction) depending upon the Bishop score, labor was induced with prostaglandins or amniotomy. In Group B (Expectant), expectant management was followed with feto-maternal monitoring. Maternal monitoring was done with blood pressure recording and laboratory tests while fetal monitoring was done by keeping maternal fetal kick count record, recording CTG and biophysical profile. Student t-test was used to analyze numerical data and Chi-square for qualitative data. A p-value of <0.05 was taken as statistically significant. RESULTS: There were more maternal complications in expectant management group as compared to induction group, while neonatal outcomes were comparable in both groups. CONCLUSION: In mild pre-eclampsia, induction of labor at term is beneficial for mother, but there is no difference in neonatal outcome in the two modes of management.


Assuntos
Trabalho de Parto Induzido/métodos , Ocitócicos/administração & dosagem , Pré-Eclâmpsia , Nascimento a Termo , Adulto , Procedimentos Cirúrgicos Eletivos , Feminino , Idade Gestacional , Humanos , Gravidez , Resultado da Gravidez , Prostaglandinas/administração & dosagem
5.
Pak J Med Sci ; 33(6): 1376-1380, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29492062

RESUMO

BACKGROUND & OBJECTIVE: To evaluate usefulness of immunohistochemical marker C-kit (CD117) in differentiating Adenoid cystic carcinoma (AdCC) from Polymorphous low-grade adenocarcinoma (PLGA) in patients of salivary gland carcinomas. AdCC is a malignant salivary gland neoplasm with poor prognosis. PLGA is a salivary gland malignancy with indolent growth pattern. Differentiating between the two entities is a diagnostic challenge. We evaluated the role of C-kit in differentiating the two. METHODS: This is a Cross sectional study. Samples of 19 tumors including 12 AdCC and 4 PLGA was evaluated at Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi from December 2015 to August 2016. Immunohistochemical techniques were used to analyze the level of c-kit expression in AdCC (n = 12), polymorphous low-grade adenocarcinoma (PLGA) (n = 6). Samples were stained using monoclonal antibody against C-kit. Statistical analysis of the data was done using SPSS version 21. RESULTS: Strong diffuse cytoplasmic reactivity was observed in more than 50% of the tumor cells of AdCC whereas less than 20% of cells showed negative to weak positivity in PLGA. Hence, the difference in the expression of c-kit between AdCC and PLGA was statistically significant (p value <0.002). CONCLUSIONS: CD117 expression itself can be used as a marker in differential diagnosis of salivary gland neoplasms. However, the percentage of the CD117 immunoreactive cells and the staining intensities appeared to be important factors in distinguishing AdCC from PLGA.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA